ArticleInternational journal of clinical oncology2024

Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor.

Yutaka Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.